Tan Ho

Array ( [id] => 10258561 [patent_doc_number] => 20150143558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'NON-HUMAN ANIMALS HAVING A HUMANIZED B-CELL ACTIVATING FACTOR GENE' [patent_app_type] => utility [patent_app_number] => 14/537312 [patent_app_country] => US [patent_app_date] => 2014-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17559 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14537312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17323819 [patent_doc_number] => 11214815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-04 [patent_title] => Nucleic acid Construct [patent_app_type] => utility [patent_app_number] => 14/519117 [patent_app_country] => US [patent_app_date] => 2014-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21390 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14519117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13090149 [patent_doc_number] => 10064398 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-04 [patent_title] => Animal models and therapeutic molecules [patent_app_type] => utility [patent_app_number] => 14/516461 [patent_app_country] => US [patent_app_date] => 2014-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 63 [patent_no_of_words] => 34868 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 474 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14516461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9857283 [patent_doc_number] => 20150037300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'NUCLEIC ACID FOR TREATMENT OR PREVENTION OF IMMUNODEFICIENCY VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 14/515817 [patent_app_country] => US [patent_app_date] => 2014-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10314 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14515817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10221968 [patent_doc_number] => 20150106961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'Humanized IL-15 Animals' [patent_app_type] => utility [patent_app_number] => 14/514454 [patent_app_country] => US [patent_app_date] => 2014-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11818 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14514454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10221971 [patent_doc_number] => 20150106963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'CYB5 AND CYP17 MUTATIONS FOR ALTERATION OF 16-ANDROSTENE STEROID SYNTHESIS AND REDUCED BOAR TAINT IN PIGS' [patent_app_type] => utility [patent_app_number] => 14/512797 [patent_app_country] => US [patent_app_date] => 2014-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 22934 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14512797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10254969 [patent_doc_number] => 20150139966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'METHODS OF USING HCN GENES TO TREAT CARDIAC ARRHYTHMIAS' [patent_app_type] => utility [patent_app_number] => 14/509629 [patent_app_country] => US [patent_app_date] => 2014-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12968 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14509629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10228675 [patent_doc_number] => 20150113669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'Animal Models and Therapeutic Molecules' [patent_app_type] => utility [patent_app_number] => 14/497054 [patent_app_country] => US [patent_app_date] => 2014-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 36823 [patent_no_of_claims] => 122 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14497054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9805182 [patent_doc_number] => 20150017127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS' [patent_app_type] => utility [patent_app_number] => 14/485472 [patent_app_country] => US [patent_app_date] => 2014-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 21084 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14485472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10219508 [patent_doc_number] => 20150104500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'Methods and Compositions for Preventing a Condition' [patent_app_type] => utility [patent_app_number] => 14/472197 [patent_app_country] => US [patent_app_date] => 2014-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 33747 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14472197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10510455 [patent_doc_number] => 09238028 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-19 [patent_title] => 'HDAC inhibitors to treat charcot-marie-tooth disease' [patent_app_type] => utility [patent_app_number] => 14/335716 [patent_app_country] => US [patent_app_date] => 2014-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 38 [patent_no_of_words] => 11421 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14335716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202066 [patent_doc_number] => 20150087054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'IMPORTATION OF MITOCHODRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH' [patent_app_type] => utility [patent_app_number] => 14/323393 [patent_app_country] => US [patent_app_date] => 2014-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 19841 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10974835 [patent_doc_number] => 20140377869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'IMPORTATION OF MITOCHODRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH' [patent_app_type] => utility [patent_app_number] => 14/323240 [patent_app_country] => US [patent_app_date] => 2014-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 19849 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16817000 [patent_doc_number] => 11001807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-11 [patent_title] => Differentiation of pluripotent stem cells and cardiac progenitor cells into striated cardiomyocyte fibers using laminins LN-511, LN-521 and LN-221 [patent_app_type] => utility [patent_app_number] => 14/895669 [patent_app_country] => US [patent_app_date] => 2014-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 9151 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14895669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10791822 [patent_doc_number] => 20160137978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'METHODS AND COMPOSITIONS FOR PRODUCING GERM CELLS FROM BONE MARROW DERIVED GERMLINE STEM CELLS' [patent_app_type] => utility [patent_app_number] => 14/308048 [patent_app_country] => US [patent_app_date] => 2014-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27034 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14308048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10784405 [patent_doc_number] => 20160130561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-12 [patent_title] => 'PLURIPOTENT STEM CELLS DERIVED FROM NON-CRYOPROTECTED FROZEN TISSUE AND METHODS FOR MAKING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 14/897225 [patent_app_country] => US [patent_app_date] => 2014-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11959 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10912284 [patent_doc_number] => 20140315301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'ISOLATED NAIVE PLURIPOTENT STEM CELLS AND METHODS OF GENERATING SAME' [patent_app_type] => utility [patent_app_number] => 14/259997 [patent_app_country] => US [patent_app_date] => 2014-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 160 [patent_figures_cnt] => 160 [patent_no_of_words] => 96865 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14259997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12111807 [patent_doc_number] => 09867785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-16 [patent_title] => 'Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells' [patent_app_type] => utility [patent_app_number] => 14/249214 [patent_app_country] => US [patent_app_date] => 2014-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17783 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14249214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10398262 [patent_doc_number] => 20150283270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'MODELING ANTI-LEUKEMIC THERAPY BY PATIENT DERIVED AML XENOGRAFTS WITH DISTINCT PHENOTYPES/GENOTYPES' [patent_app_type] => utility [patent_app_number] => 14/246018 [patent_app_country] => US [patent_app_date] => 2014-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7896 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14246018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11269262 [patent_doc_number] => 20160331809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-17 [patent_title] => 'THE USE OF SDF-1 TO MITIGATE SCAR FORMATION' [patent_app_type] => utility [patent_app_number] => 14/773953 [patent_app_country] => US [patent_app_date] => 2014-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12542 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773953 [rel_patent_id] =>[rel_patent_doc_number] =>)